OHRP, FDA Extend Comment Period for Draft Guidance on Institutional Review Board Meetings

Summary

The Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) are extending the comment period for draft guidance on Institutional Review Board meetings by 30 days, allowing interested persons more time to submit comments.